Tenaya Therapeutics Inc. (TNYA)
undefined
undefined%
At close: undefined
2.85
3.67%
After-hours Dec 13, 2024, 07:58 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19
Revenue - - - - -
Cost of Revenue 8.69M 8.71M 4.03M 2.48M 1.99M
Gross Profit -8.69M -8.71M -4.03M -2.48M -1.99M
Operating Income -131.19M -125.62M -72.81M -38.91M -27.71M
Interest Income 7.06M 1.95M 108.00K 87.00K 453.00K
Pretax Income -124.08M -123.67M -72.72M -38.40M -26.23M
Net Income -124.08M -123.66M -69.65M -38.31M -25.78M
Selling & General & Admin 33.16M 31.08M 18.41M 7.81M 4.56M
Research & Development 98.04M 94.54M 54.39M 31.10M 23.15M
Other Expenses - 2.00K -23.00K 430.00K 1.03M
Operating Expenses 131.19M 125.62M 72.81M 38.91M 27.71M
Interest Expense - - - - -
Selling & Marketing Expenses - - - - -
Cost & Expenses 131.19M 125.62M 72.81M 38.91M 27.71M
Income Tax - -1.96K -3.07M -87.00K -453.00K
Shares Outstanding (Basic) 73.79M 44.82M 41.29M 41.12M 41.12M
Shares Outstanding (Diluted) 73.79M 44.82M 41.29M 41.12M 41.12M
EPS (Basic) -1.68 -2.76 -1.69 -0.93 -0.63
EPS (Diluted) -1.68 -2.76 -1.69 -0.93 -0.63
EBITDA -122.51M -114.95M -68.70M -36.43M -25.72M
Depreciation & Amortization 8.69M 8.71M 4.03M 2.48M 1.99M